| Observation of the Natural Course of Age-related Macular Degeneration (NCT05418231) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2022-07-01 |
| Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) (NCT05447650) | i-Lumen Scientific, Inc. | 2022-04-12 |
| Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) (NCT04627428) | Luxa Biotechnology, LLC | 2022-04-05 |
| Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA) (NCT04358471) | Hemera Biosciences | 2021-07-31 |
| Microcurrent Stimulation for Dry Age-related Macular Degeneration (NCT04511936) | i-Lumen Scientific, Inc. | 2021-03-01 |
| CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration (NCT04636853) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2020-12-23 |
| HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 (NCT04566445) | Gyroscope Therapeutics Limited | 2020-09-28 |
| Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration (NCT04339764) | National Eye Institute (NEI) | 2020-09-23 |
| Observational Study of Vision Improvement in Late Stage Dry AMD Patients (NCT04349254) | Optimal Acuity Corporation | 2020-08-14 |
| A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration (NCT04643886) | Gemini Therapeutics, Inc. | 2020-07-30 |
| First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration (NCT04246866) | Gemini Therapeutics, Inc. | 2019-12-19 |
| Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III) (NCT04065490) | LumiThera, Inc. | 2019-09-01 |
| EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 (NCT04437368) | Gyroscope Therapeutics Limited | 2019-04-26 |
| Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II) (NCT03878420) | LumiThera, Inc. | 2019-02-14 |
| GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) (NCT03894020) | Gyroscope Therapeutics Limited | 2019-01-08 |
| FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD (NCT03846193) | Gyroscope Therapeutics Limited | 2018-12-17 |
| PRIMA US-Feasibility Study in Atrophic Dry AMD (NCT03392324) | Science Corporation | 2018-04-26 |
| Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases (NCT02755428) | Chinese Academy of Sciences | 2018-01-01 |
| Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration (NCT03333954) | Science Corporation | 2017-11-06 |
| Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells (NCT03046407) | Chinese Academy of Sciences | 2017-09-06 |
| A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration (NCT03626636) | Allegro Ophthalmics, LLC | 2017-08-01 |
| Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59 (NCT03144999) | Janssen Research & Development, LLC | 2017-03-29 |
| The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD (NCT03305029) | CHA University | 2016-05-01 |
| Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration (NCT02686658) | IVERIC bio, Inc. | 2015-12-15 |
| A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD (NCT01674829) | CHABiotech CO., Ltd | 2012-09-01 |
| Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (NCT01344993) | Astellas Institute for Regenerative Medicine | 2011-06-09 |
| A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration (NCT01379560) | Sucampo Pharma Americas, LLC | 2011-05-01 |
| Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy (NCT01002950) | Kubota Vision Inc. | 2009-10-01 |
| A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration (NCT00950638) | Ophthotech Corporation | 2009-07-16 |
| Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD (NCT00926861) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2009-07-01 |
| Transcorneal Electrical Stimulation Therapy for Retinal Disease (NCT00804102) | Okuvision GmbH | 2008-01-01 |
| Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration (NCT00541333) | The New York Eye & Ear Infirmary | 2007-12-01 |
| Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration (NCT00429936) | Sirion Therapeutics, Inc. | 2006-12-01 |
| Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial (NCT00751361) | Apheresis Research Institute | 1998-11-01 |